In-vivo Imaging Market: Global Demand Analysis & Opportunity Outlook 2036

Research Nester’s recent market research analysis on “In-vivo Imaging Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global In-vivo imaging market in terms of market segmentation by modality, technique, end-user, reagents and by region.

Growing Usage in Drug Discovery to Promote Global Market Share of In-vivo Imaging

The global In-vivo imaging market is estimated to grow majorly on account of the increasing use of In-vivo imaging techniques in drug development. In vivo, imaging technologies are now a crucial and fundamental part of drug discovery and have evolved to be one of the most powerful methods to assist modern drug development by assessing safety and toxicology. Moreover, they disclose how drugs affect entire, complex organisms, help in increasing the likelihood of clinical success, and cut down on the time and expense of drug research and development.

The global In-vivo imaging market is estimated to grow majorly on account of the increasing use of In-vivo imaging techniques in personalized medicine. Precision medicine is a cutting-edge method that considers a person's genetics, environment, and lifestyle when choosing treatment to personalize disease prevention. In vivo imaging is a crucial component of precision medicine, allowing for more accurate diagnosis and real-time therapy, can also be used to stratify patients and reduce adverse medication effects.

In addition, the increasing popularity of minimally invasive procedures is expected to drive market growth. Physicians and patients are increasingly choosing minimally invasive surgery as these operations need fewer incisions, cause less discomfort, and leave no unsightly scars. This has led to an increase in demand for In-vivo imaging techniques which is a non-invasive procedure that is becoming a crucial tool for fundamental and preclinical research as it employs fluorescent or bioluminescent sensors to monitor molecular and biological processes.

Some of the major growth factors and challenges that are associated with the growth of the global In-vivo imaging market are:

Growth Drivers:

Challenges:

The exorbitant cost of In-vivo imaging procedures, and the compliance regulations are some of the major factors anticipated to hamper the global market size of In-vivo imaging. This imaging procedure involves the usage of advanced equipment such as CT scanners and MRI machines, which are expensive to maintain and purchase. Besides this, the procedure involves the requirement of highly skilled medical professionals that can be expensive to acquire. Therefore, all these factors add to the overall cost of the procedure.

Access our detailed report at: https://www.researchnester.com/reports/in-vivo-imaging-market/5231

By modality, the global In-vivo imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI, micro-ultrasound, micro-CT, photoacoustic imaging systems, and magnetic particle imaging systems. The optical imaging systems segment is to garner the highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. Optical in vivo imaging systems are a potent tool that enables scientists to observe biological processes and examine plants and tiny animals. It is a non-invasive imaging method employing bioluminescent or fluorescent materials in which the contrast used interacts with the visible and near-infrared light wavelengths in live tissues.

In addition, nuclear imaging systems are to garner notable revenue over the forecast period. Nuclear molecular imaging technologies (PET and SPECT) detect radiation from various body areas after administering a radioactive tracer substance for the diagnosis and treatment of differentiated thyroid cancer.

By region, the Europe In-vivo imaging market is to generate the highest revenue by the end of 2036. This growth is anticipated by increasing advancement in healthcare services. Numerous European nations are making significant investments in AI research and development to enhance patient outcomes and offer significant advancements in all facets of healthcare. As a result, diagnosis for several diseases has improved in the region, leading to a higher demand for In-vivo imaging.

 Besides this, the growing elderly population in the region may create a huge demand for In-vivo imaging. The proportion of old people in Europe is the highest, and today, one in five people in the country is 65 or older. For instance, Italy had the highest proportion of elderly people in Europe in 2022, accounting for more than 22% of the total population. This may increase the burden of chronic diseases in the region which would necessitate the use of In-vivo imaging methods for timely diagnosis of these diseases.

This report also provides the existing competitive scenario of some of the key players of the global In-vivo imaging market which includes company profiling of Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec , CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions, Trifoil Imaging  and others.